144 related articles for article (PubMed ID: 36757165)
1. Adverse Effects of Tacrolimus and Its Associated Risk Factors in Renal Transplant Recipients.
Meera M; Manikandan S; Parameswaran S
Exp Clin Transplant; 2023 Jan; 21(1):22-27. PubMed ID: 36757165
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus after kidney transplantation in Japanese patients: The Japan Academic Consortium of Kidney Transplantation study.
Okumi M; Unagami K; Hirai T; Shimizu T; Ishida H; Tanabe K;
Int J Urol; 2017 Mar; 24(3):197-204. PubMed ID: 27862344
[TBL] [Abstract][Full Text] [Related]
3. Conversion From Steroid to Everolimus in Maintenance Kidney Transplant Recipients With Posttransplant Diabetes Mellitus.
Nanmoku K; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Yagisawa T
Exp Clin Transplant; 2019 Feb; 17(1):47-51. PubMed ID: 29911959
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations.
Varghese J; Reddy MS; Venugopal K; Perumalla R; Narasimhan G; Arikichenin O; Shanmugam V; Shanmugam N; Srinivasan V; Jayanthi V; Rela M
Indian J Gastroenterol; 2014 May; 33(3):219-25. PubMed ID: 24740447
[TBL] [Abstract][Full Text] [Related]
5. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus.
Bloom RD; Rao V; Weng F; Grossman RA; Cohen D; Mange KC
J Am Soc Nephrol; 2002 May; 13(5):1374-80. PubMed ID: 11961026
[TBL] [Abstract][Full Text] [Related]
6. Posttransplant metabolic complications in living-related renal allograft recipients of Kashmir Valley.
Shera IA; Yousuf Q; Mir MA; Wani IA; Najar MS
Exp Clin Transplant; 2014 Feb; 12(1):25-30. PubMed ID: 24471720
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Miller J; Mendez R; Pirsch JD; Jensik SC
Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543
[TBL] [Abstract][Full Text] [Related]
8. Posttransplant diabetes mellitus among live-related kidney transplant recipients: Sindh Institute of Urology and Transplantation experience.
Mohammad KG; Idrees MK; Ali T; Akhtar F
Saudi J Kidney Dis Transpl; 2018; 29(6):1320-1325. PubMed ID: 30588962
[TBL] [Abstract][Full Text] [Related]
9. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
[TBL] [Abstract][Full Text] [Related]
10. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
[TBL] [Abstract][Full Text] [Related]
11. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.
Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G
Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338
[TBL] [Abstract][Full Text] [Related]
12. Modifiable Variables Are Major Risk Factors for Posttransplant Diabetes Mellitus in a Time-Dependent Manner in Kidney Transplant: An Observational Cohort Study.
de Lucena DD; de Sá JR; Medina-Pestana JO; Rangel ÉB
J Diabetes Res; 2020; 2020():1938703. PubMed ID: 32258163
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus.
Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Valga EF; Barrientos A
Transplant Proc; 2010 Oct; 42(8):2902-4. PubMed ID: 20970565
[TBL] [Abstract][Full Text] [Related]
14. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors.
Maes BD; Kuypers D; Messiaen T; Evenepoel P; Mathieu C; Coosemans W; Pirenne J; Vanrenterghem YF
Transplantation; 2001 Nov; 72(10):1655-61. PubMed ID: 11726827
[TBL] [Abstract][Full Text] [Related]
15. Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review.
Braithwaite HE; Darley DR; Brett J; Day RO; Carland JE
Transplant Rev (Orlando); 2021 Apr; 35(2):100610. PubMed ID: 33756310
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Tacrolimus Trough Level in Patients Who Developed Post-transplant Diabetes Mellitus After Kidney Transplantation: A Retrospective Single-Center Study in Saudi Arabia.
Ajabnoor A; Nasser M; Khan N; Habhab W
Transplant Proc; 2020 Dec; 52(10):3160-3167. PubMed ID: 32636070
[TBL] [Abstract][Full Text] [Related]
17. Posttransplant diabetes mellitus: incidence and risk factors.
Mazali FC; Lalli CA; Alves-Filho G; Mazzali M
Transplant Proc; 2008 Apr; 40(3):764-6. PubMed ID: 18455010
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients.
Jung HY; Seo MY; Jeon Y; Huh KH; Park JB; Jung CW; Lee S; Han SY; Ro H; Yang J; Ahn C; Choi JY; Cho JH; Park SH; Kim YL; Kim CD
PLoS One; 2020; 15(7):e0235418. PubMed ID: 32614859
[TBL] [Abstract][Full Text] [Related]
19. Changes in the commercial brand of tacrolimus lead to subtherapeutic trough levels and acute rejection in renal transplant recipients.
Arreola-Guerra JM; Alberú J; Chew-Wong A; Macias DM; Hernández-Rosales J; Zuñiga-Macías L; Delgadillo-Castañeda R; Ricalde-Ríos G; Haro-Alcalde F; Villafán-Bernal JR; Ramos-Medellín CL; Reyes-Acevedo R
Clin Transplant; 2019 Dec; 33(12):e13749. PubMed ID: 31691354
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Everolimus Plus Standard-Dose Tacrolimus Immunosuppression in De Novo Kidney Transplant: A Retrospective, Single-Center Study of 225 Transplants.
Okabe Y; Noguchi H; Sato Y; Mei T; Kaku K; Ueki K; Tsuchimoto A; Nakamura M
Exp Clin Transplant; 2022 Mar; 20(4):362-369. PubMed ID: 35475420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
